Twitter advertising pause or persist? Pharmas quietly weigh options in uncertain time
As Elon Musk’s takeover of Twitter — and almost-daily controversies — causes confusion and consternation, brand advertisers on the platform are trying to figure out what to do. And that includes pharma advertisers.
So far, the lone publicly on-the-record pharma pausing its advertising on the platform is Gilead Sciences and its subsidiary Kite.
Gilead initially said last week that it was temporarily pausing Twitter advertising. However, it amended its stance on Monday to remove the word “temporarily.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.